DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $213,000 | -78.6% | 841 | -75.2% | 0.04% | -69.5% |
| Q1 2022 | $994,000 | -71.0% | 3,387 | -67.5% | 0.12% | -68.1% |
| Q4 2021 | $3,429,000 | -15.1% | 10,422 | -21.5% | 0.37% | -15.1% |
| Q3 2021 | $4,041,000 | +26.0% | 13,272 | +11.1% | 0.44% | +26.4% |
| Q2 2021 | $3,207,000 | +158.2% | 11,951 | +116.6% | 0.34% | +144.7% |
| Q1 2021 | $1,242,000 | +0.3% | 5,518 | -1.0% | 0.14% | -1.4% |
| Q4 2020 | $1,238,000 | +2.6% | 5,573 | -0.6% | 0.14% | -13.9% |
| Q3 2020 | $1,207,000 | +17.4% | 5,607 | -3.5% | 0.17% | +8.5% |
| Q2 2020 | $1,028,000 | +26.6% | 5,812 | -0.9% | 0.15% | 0.0% |
| Q1 2020 | $812,000 | -23.0% | 5,866 | -14.7% | 0.15% | +13.3% |
| Q4 2019 | $1,055,000 | +6.4% | 6,876 | +0.2% | 0.14% | -2.9% |
| Q3 2019 | $992,000 | +0.3% | 6,865 | -0.8% | 0.14% | +6.1% |
| Q2 2019 | $989,000 | +3.5% | 6,917 | -4.5% | 0.13% | +1.6% |
| Q1 2019 | $956,000 | +28.0% | 7,246 | 0.0% | 0.13% | -7.9% |
| Q4 2018 | $747,000 | +121.7% | 7,246 | +133.8% | 0.14% | +218.2% |
| Q3 2018 | $337,000 | +52.5% | 3,099 | +38.1% | 0.04% | +18.9% |
| Q2 2018 | $221,000 | +0.5% | 2,244 | 0.0% | 0.04% | -11.9% |
| Q1 2018 | $220,000 | +5.8% | 2,244 | 0.0% | 0.04% | +31.2% |
| Q4 2017 | $208,000 | -94.9% | 2,244 | -94.9% | 0.03% | -96.9% |
| Q4 2015 | $4,096,000 | +91.8% | 44,102 | +76.0% | 1.03% | +65.2% |
| Q3 2015 | $2,136,000 | -42.4% | 25,063 | -47.9% | 0.62% | -53.9% |
| Q4 2013 | $3,710,000 | – | 48,063 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |